(4Z,4′Z)-2,2′-(Ethane-1,2-diylbis(sulfanediyl))bis(1-phenyl)-4-(pyridin-2-ylmethylene)-1H-imidazol-5(4H)-one)dicopper(II) Tetrabromide
Abstract
:1. Introduction
2. Results
3. Experimental Section
(4Z,4′Z)-2,2′-(Ethane-1,2-diylbis(sulfanediyl))bis(1-phenyl)-4-(pyridin-2-ylmethylene)-1H-imidazol-5(4H)-one)dicopper(II) Tetrabromide (2)
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Guk, D.A.; Krasnovskaya, O.O.; Beloglazkina, E.K. Coordination compounds of biogenic metals as cytotoxic agents in cancer therapy. Russ. Chem. Rev. 2021, 90, 1566–1623. [Google Scholar] [CrossRef]
- Ndagi, U.; Mhlongo, N.; Soliman, M. Metal complexes in cancer therapy—An update from drug design perspective. Drug Des. Dev. Ther. 2017, 11, 599–616. [Google Scholar] [CrossRef] [PubMed]
- Prosser, K.E.; Chang, S.W.; Saraci, F.; Le, P.H.; Walsby, C.J. Anticancer copper pyridine benzimidazole complexes: ROS generation, biomolecule interactions, and cytotoxicity. J. Inorg. Biochem. 2017, 167, 89–99. [Google Scholar] [CrossRef] [PubMed]
- Acilan, C.; Cevatemre, B.; Adiguzel, Z.; Karakas, D.; Ulukaya, E.; Ribeiro, N.; Correi, I.; Pessoa, J.C. Synthesis, biological characterization and evaluation of molecular mechanisms of novel copper complexes as anticancer agents. Biochim. Biophys. Acta (BBA) Gen. Subj. 2017, 1861, 218–234. [Google Scholar] [CrossRef] [PubMed]
- Reina, M.; Hernández-Ayala, L.F.; Bravo-Gómez, M.E.; Gómez, V.; Ruiz-Azuara, L. Second generation of Casiopeinas: A joint experimental and theoretical study. Inorg. Chim. Acta 2021, 517, 120201. [Google Scholar] [CrossRef]
- Alem, M.B.; Damena, T.; Desalegn, T.; Koobotse, M.; Eswaramoorthy, R.; Ngwira, K.J.; Ombito, J.O.; Zachariah, M.; Demissie, T.B. Cytotoxic mixedligand complexes of Cu(II): A combined experimental and computational study. Front. Chem. 2022, 10, 1028957. [Google Scholar] [CrossRef] [PubMed]
- Drzewiecka-Antonik, A.; Rejmak, P.; Klepka, M.; Wolska, A.; Chrzanowska, A.; Struga, M. Structure and anticancer activity of Cu(II) complexes with (bromophenyl)thiourea moiety attached to the polycyclic imide. J. Inorg. Biochem. 2020, 212, 111234. [Google Scholar] [CrossRef] [PubMed]
- Krasnovskaya, O.O.; Guk, D.A.; Naumov, A.E.; Nikitina, V.N.; Semkina, A.S.; Vlasova, K.Y.; Pokrovsky, V.; Ryabaya, O.O.; Karshieva, S.S.; Skvortsov, D.A.; et al. Novel Copper-Containing Cytotoxic Agents Based on 2-Thioxoimidazolones. J. Med. Chem. 2020, 63, 13031–13063. [Google Scholar] [CrossRef] [PubMed]
- Finko, A.V.; Guk, D.A.; Saakian, A.S.; Moiseeva, A.A.; Tafeenko, V.A.; Shiryaeva, E.S.; Pergushov, V.I.; Melnikov, M.Y.; Komlev, A.S.; Beloglazkin, A.A.; et al. Structurally similar mixed-valent coordination compounds formed during the interaction of bis-5-pyridylmethylene-2-thioimidazolone with CuBr2 и CuCl2. Polyhedron 2022, 225, 115998. [Google Scholar] [CrossRef]
- Finko, A.V.; Sokolov, A.I.; Guk, D.A.; Tafeenko, V.A.; Moiseeva, A.A.; Skvortsov, D.A.; Stomakhin, A.A.; Beloglazkin, A.A.; Borisov, R.S.; Pergushov, V.I.; et al. Copper coordination compounds with (5Z,5Z′)-2,2′-(alkane-α,ω-diyldiselenyl)-bis-5-(2-pyridylmethylene)-3,5-dihydro-4H-imidazol-4-ones. Comparison with sulfur analogue. RSC Adv. 2022, 12, 7133–7148. [Google Scholar] [CrossRef] [PubMed]
- Sheldrick, G.M. A short history of SHELX. Acta Crystallogr. A 2008, A64, 112–122. [Google Scholar] [CrossRef] [PubMed]
- Brandenburg, K.; Brendt, M. DIAMOND, Release 2.1 d; Crystal Impact GbR: Bonn, Germany, 2000; pp. 302–303. [Google Scholar]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Al-Khazraji, A.S.H.; Berezina, A.V.; Bai, X.; Tafeenko, V.A.; Borisov, R.S.; Ofitserov, E.N.; Bian, J.; Shtil, A.A.; Finko, A.V. (4Z,4′Z)-2,2′-(Ethane-1,2-diylbis(sulfanediyl))bis(1-phenyl)-4-(pyridin-2-ylmethylene)-1H-imidazol-5(4H)-one)dicopper(II) Tetrabromide. Molbank 2023, 2023, M1638. https://doi.org/10.3390/M1638
Al-Khazraji ASH, Berezina AV, Bai X, Tafeenko VA, Borisov RS, Ofitserov EN, Bian J, Shtil AA, Finko AV. (4Z,4′Z)-2,2′-(Ethane-1,2-diylbis(sulfanediyl))bis(1-phenyl)-4-(pyridin-2-ylmethylene)-1H-imidazol-5(4H)-one)dicopper(II) Tetrabromide. Molbank. 2023; 2023(2):M1638. https://doi.org/10.3390/M1638
Chicago/Turabian StyleAl-Khazraji, Ahmed S. H., Anna V. Berezina, Xiumei Bai, Victor A. Tafeenko, Roman S. Borisov, Evgeny N. Ofitserov, Jinlei Bian, Alexander A. Shtil, and Alexander V. Finko. 2023. "(4Z,4′Z)-2,2′-(Ethane-1,2-diylbis(sulfanediyl))bis(1-phenyl)-4-(pyridin-2-ylmethylene)-1H-imidazol-5(4H)-one)dicopper(II) Tetrabromide" Molbank 2023, no. 2: M1638. https://doi.org/10.3390/M1638